Is Excess Weight Causing Your Low Testosterone? When Weight Loss May Come Before TRT

By R. Robert Dhir

Fatigue, reduced sex drive, erectile changes, weight gain, and loss of muscle can make a man wonder whether his testosterone is low. But the next question matters just as much: Why is it low?

For many men carrying excess weight, a low testosterone result may be partly driven by obesity, insulin resistance, poor sleep, or obstructive sleep apnea. In that situation, immediately prescribing testosterone can improve a laboratory number without fully addressing the condition suppressing the body’s natural hormone production.

Comprehensive men’s health care should begin with a physician-led evaluation of hormonal, metabolic, sexual, reproductive, and urologic health—not a predetermined prescription. For an appropriate patient, weight loss supported by tirzepatide may help natural testosterone production. Other men have true hypogonadism and may benefit from testosterone replacement therapy (TRT) or a fertility-preserving alternative.

The goal is to identify the cause and build the right plan.

The short answer: Can losing weight raise testosterone?

Yes, it can—especially when excess weight is a major cause of the low level. Testosterone often improves as men with obesity lose meaningful weight, although the response varies and normalization is not guaranteed.

In July 2026, the Endocrine Society emphasized that men should be diagnosed with hypogonadism based on compatible symptoms plus consistently low, accurately measured testosterone levels. It also stated that when low testosterone is attributable to overweight or obesity and no other cause is identified, weight loss is typically first-line therapy.

This does not mean that every man with a higher body mass index has “temporary” low T, or that a man with significant symptoms should simply be told to exercise more. It means his physician should distinguish a potentially reversible reduction in testosterone from testicular, pituitary, hypothalamic, medication-related, or other causes of hypogonadism.

How excess weight can suppress male hormone function

The relationship runs in both directions. Lower testosterone can contribute to reduced muscle mass and increased fat mass. Excess adipose tissue and related metabolic conditions can suppress the hypothalamic-pituitary-gonadal axis—the signaling system connecting the brain, pituitary gland, and testicles.

Several factors may contribute:

This is one reason symptoms alone cannot diagnose low T. Fatigue, low libido, weight gain, and reduced performance can result from several overlapping problems.

Where Tirzepatide may fit

Tirzepatide is a once-weekly medication that activates GIP and GLP-1 receptors. The FDA-approved obesity formulation is indicated for long-term weight reduction in adults with obesity or overweight, plus at least one weight-related condition, when used with reduced-calorie nutrition and increased physical activity. It is also FDA-approved for moderate-to-severe obstructive sleep apnea in adults with obesity.

In the pivotal 72-week obesity trial summarized in the current FDA label, average body-weight reductions were approximately 15.0%, 19.5%, and 20.9% at the studied maintenance doses, compared with 3.1% with placebo. Those are study averages—not a promise of an individual result—and medication should be one component of a long-term health strategy.

Tirzepatide is not testosterone, and it is not FDA-approved to treat low testosterone. Its potential hormone benefit is indirect: if excess adiposity, insulin resistance, and sleep apnea are suppressing testosterone, substantial weight loss may reduce those pressures and allow endogenous testosterone production to recover.

Early research on anti-obesity medications and male hormones is encouraging, but it is not yet appropriate to promise that tirzepatide will normalize testosterone. Testosterone and symptoms should be reassessed over time rather than assuming that weight loss automatically solves every case.

Should weight loss come before TRT—or can they be used together?

There is no single sequence for every patient. A physician should consider the severity and cause of the hormone deficiency, symptoms, fertility plans, body composition, metabolic risk, sleep health, and patient preferences.

Clinical situationA reasonable physician-led approach may include
Excess weight, borderline-low testosterone, and no clear testicular or pituitary disorderPrioritize sustainable weight loss, sleep-apnea assessment, metabolic treatment, and repeat hormone testing
Consistently low morning testosterone with symptoms and an identified testicular, pituitary, or hypothalamic causeDiscuss TRT after reviewing benefits, risks, fertility goals, and the required monitoring
Low T in a man who wants to preserve fertilityAvoid reflexive use of exogenous testosterone; consider a fertility evaluation and appropriate alternatives that stimulate endogenous production
Significant obesity plus established hypogonadismConsider a combined metabolic and hormone strategy when medically appropriate rather than treating either problem in isolation
Very low testosterone, headaches, visual symptoms, testicular changes, breast symptoms, or abnormal pituitary hormonesPerform a more urgent diagnostic evaluation instead of assuming weight is the sole cause

For some men already using TRT, medically supervised weight loss can be added to address cardiometabolic risk and improve body composition. For others, a weight-first strategy may clarify whether exogenous testosterone is needed at all. Men should not stop prescribed testosterone or change doses without discussing it with their treating physician.

What a comprehensive low-testosterone evaluation should include

A high-quality evaluation is more than a single testosterone test and a standard injection protocol. Depending on the patient, Dr. Dhir may consider:

This evaluation may lead to lifestyle and weight-loss treatment, tirzepatide or another anti-obesity medication for an appropriate candidate, TRT, oral testosterone, pellets, injections, or a fertility-preserving option such as a SERM or hCG. The right treatment depends on the diagnosis—not on a clinic’s default protocol.

Protecting muscle while losing weight

Men seeking weight loss often care as much about strength and body composition as the number on the scale. Because a significant calorie deficit can reduce fat and lean mass, muscle preservation is an important part of a GLP-1–based program.

A personalized plan may include:

The aim is to improve metabolic health while preserving muscle, energy, sexual function, and physical capacity.

Tirzepatide requires real medical screening and follow-up

Tirzepatide can be highly effective, but it is not a casual “fat-loss shot.” The current Zepbound label includes a boxed warning concerning thyroid C-cell tumors observed in rats. It is contraindicated with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.

Common adverse effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, and indigestion. Important risks include severe gastrointestinal reactions, dehydration-related kidney injury, gallbladder disease, pancreatitis, and serious hypersensitivity reactions. It is not recommended for patients with severe gastroparesis. A prescriber should also review diabetes medications, upcoming procedures requiring anesthesia or deep sedation, and other patient-specific risks.

Careful dose escalation, nutrition and hydration guidance, side-effect management, and follow-up are part of treatment—not optional extras.

Why a urologist-led men’s health plan is different

Weight, testosterone, erections, libido, fertility, sleep, and urinary health are often connected. A board-certified urologist can evaluate those relationships rather than reducing the visit to one symptom or one prescription.

At HTX Urology, Dr. R. Robert Dhir provides individualized men’s health care for patients in Webster, Clear Lake, League City, Friendswood, and the greater Houston area. Treatment can integrate medical weight management, hormone optimization, fertility preservation, erectile dysfunction care, and broader urologic health within one physician-led plan.

If you are gaining weight, feeling less energetic, losing strength, experiencing sexual changes, or questioning whether your current low-T treatment addresses the underlying problem, schedule a comprehensive evaluation. The most useful answer is not simply whether your testosterone is low—it is why, and what combination of treatments can improve your health safely.

Schedule a men’s health consultation with HTX Urology or call (281) 946-6462.

Frequently asked questions

Can tirzepatide increase testosterone in men?

It may indirectly improve testosterone in some men when obesity and related metabolic problems are suppressing natural hormone production. Tirzepatide is not testosterone therapy and is not FDA-approved to treat hypogonadism. The degree of hormone improvement varies, so symptoms and laboratory values should be reassessed during treatment.

How much weight does a man need to lose to improve testosterone?

There is no universal threshold. In general, more meaningful and sustained weight loss is associated with a greater chance of hormonal improvement, but the response depends on the cause of low testosterone, age, sleep health, diabetes, medications, and other factors.

Can a man use tirzepatide and testosterone at the same time?

Sometimes. A combined plan can be appropriate for a man with both obesity and well-established hypogonadism. It should be individualized and monitored, rather than assuming that every patient needs both medications.

Should I stop TRT after losing weight?

Do not stop or change prescribed testosterone on your own. After substantial, stable weight loss, your physician can review symptoms, laboratory results, the original cause of hypogonadism, and fertility goals to determine whether the treatment plan should change.

Does TRT affect fertility?

Yes. Exogenous testosterone can suppress the hormonal signals required for sperm production and may markedly reduce sperm counts. Men who want current or future fertility should discuss this before starting TRT; fertility-preserving approaches may be more appropriate.

Author bio

R. Robert Dhir, MD, is a board-certified urologic surgeon and founder of HTX Urology, a division of CLS Health. He earned his undergraduate and medical degrees from Georgetown University and served as chief resident during his urologic surgery residency at the University of Texas at Houston / MD Anderson Cancer Center. Dr. Dhir provides comprehensive, physician-led care in hormone optimization, erectile dysfunction, male fertility, medical weight management, and urologic health for men in Webster, Clear Lake, League City, Friendswood, and the greater Houston area.

Medical references

  1. Endocrine Society. Statement on Testosterone Replacement Therapy. July 16, 2026.
  2. American Urological Association. Testosterone Deficiency Guideline.
  3. U.S. Food and Drug Administration. Zepbound (tirzepatide) Prescribing Information. Revised February 2026.
  4. Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022;387:205–216.
  5. Endocrine Society. Testosterone Therapy for Hypogonadism Guideline Resources. 2018.

Contact Us Today!

Schedule a Consultation

Call Email Book Locations